Đang chuẩn bị liên kết để tải về tài liệu:
Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-tomesenchymal transition

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Pancreatic ductal adenocarcinoma (PDAC) patients suffer poor outcomes, including a five-year survival of below 10%. Poor outcomes result in part from therapeutic resistance that limits the impact of cytotoxic first-line therapy. Novel therapeutic approaches are needed, but currently no targeted therapies exist to treat PDAC. |

TÀI LIỆU LIÊN QUAN

A benchmark of algorithms for the analysis of pooled CRISPR screens

CRISPhieRmix: A hierarchical mixture model for CRISPR pooled screens

A genome-scale CRISPR interference guide library enables comprehensive phenotypic profiling in yeast

Identification of functional regulatory elements in the human genome using pooled CRISPR screens

Pooled extracellular receptor-ligand interaction screening using CRISPR activation

MAUDE: Inferring expression changes in sorting-based CRISPR screens

Multiple-gene targeting and mismatch tolerance can confound analysis of genome-wide pooled CRISPR screens

CRISPR library designer (CLD): Software for multispecies design of single guide RNA libraries

Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-tomesenchymal transition
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.